|
Volumn 145, Issue 3, 2008, Pages 193-206
|
Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy
|
Author keywords
Allergen specific immunotherapy; Bet v 1; Hypoallergenic variant; Recombinant allergen
|
Indexed keywords
HISTAMINE;
IMMUNOGLOBULIN E;
PROTEIN BET V 1;
RECOMBINANT ALLERGEN;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
AGED;
ALLERGENICITY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BASOPHIL;
CIRCULAR DICHROISM;
CLINICAL ARTICLE;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GEL PERMEATION CHROMATOGRAPHY;
HISTAMINE RELEASE;
HUMAN;
HUMAN CELL;
IMMUNOBLOTTING;
IMMUNOGENICITY;
IMMUNOREACTIVITY;
IMMUNOTHERAPY;
LIGHT SCATTERING;
MALE;
MOUSE;
NONHUMAN;
POLLEN ALLERGY;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
ADOLESCENT;
ADULT;
AGED;
ALLERGENS;
ANIMALS;
ANTIBODY SPECIFICITY;
BASOPHILS;
BETULA;
DESENSITIZATION, IMMUNOLOGIC;
DRUG EVALUATION, PRECLINICAL;
EPITOPES;
FEMALE;
HUMANS;
IMMUNE SERA;
IMMUNOGLOBULIN E;
LYMPHOCYTE ACTIVATION;
MALE;
MICE;
MICE, INBRED BALB C;
MIDDLE AGED;
POLLEN;
PROTEIN FOLDING;
RECOMBINANT PROTEINS;
RHINITIS, ALLERGIC, SEASONAL;
T-LYMPHOCYTES;
|
EID: 39749123322
PISSN: 10182438
EISSN: None
Source Type: Journal
DOI: 10.1159/000109288 Document Type: Article |
Times cited : (76)
|
References (51)
|